FDA OKs new flu vaccine from GlaxoSmithKline

08/18/2013 | Family Practice News · PMLive.com (U.K.)

The FDA has approved GlaxoSmithKline's Flulaval Quadrivalent vaccine for two A and two B strains of seasonal influenza. "Trivalent vaccines do reduce influenza risk, even in years when a vaccine strain-mismatch occurs, though quadrivalent influenza vaccines are the important next step in broadening strain coverage," said GSK's Dr. Leonard Friedland. The vaccine will be distributed for the coming flu season, and it is GSK's second quadrivalent flu vaccine to be approved in the U.S.

View Full Article in:

Family Practice News · PMLive.com (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA